The poly(amidoamine)s (PAAs) ISA 1 and ISA 23 display pH-dependent conformational change and pH-dependent membrane perturbation. These properties confer potential for use as endosomolytic polymers for intracytoplasmic delivery of toxins and genes. Both polymers are relatively non-toxic, and moreover ISA 23 has the beneficial property in vivo, of being non hepatotropic when administered intravenously. Although ISA 23 and ISA 1 demonstrate ability to transfect cells, ISA 1 is also able to promote intracellular delivery of non-permeant toxins. The aim of this study was to synthesise random and block copolymers of ISA 1 and ISA 23 and investigate whether these second generation hybrids would allow optimisation of PAA biological characteristics....
The pH-responsive poly(amidoamine)s (PAAs) have been previously described. Whereas ISA23 enhances tr...
A review. Poly(amidoamine)s (PAAs) are a family of synthetic polymers obtained by stepwise polyaddn...
A review. Polymer--drug and polymer--protein conjugates are emerging as a robust and well-character...
Many potential therapeutics (such as genes, antisense and protein drugs) have their targets in a var...
On exposure to an acidic pH, linear poly(amidoamine)s (PAAs) cause membrane perturbation and consequ...
Poly(amidoamine)s were synthesized by polyaddition reaction: to bis-acryloylpiperazine of piperazine...
Bioresponsive poly(amidoamine)s (PAA)s are currently under development as endosomolytic polymers for...
Poly(amidoamine)s with bioreducible disulfide linkages in the main chain (SS-PAAs) and pH-responsive...
Poly(amidoamine)s with bioreducible disulfide linkages in the main chain (SS-PAAs) and pH-responsive...
Polymer–drug and polymer–protein conjugates are emerging as a robust and well-characterized class of...
Polymer–drug and polymer–protein conjugates are emerging as a robust and well-characterized class of...
Polymer–drug and polymer–protein conjugates are emerging as a robust and well-characterized class of...
Polymer–drug and polymer–protein conjugates are emerging as a robust and well-characterized class of...
In recent years, gene, antisense and ribozyme therapies have been proposed. These systems all share ...
Poly(amido amine) (SS-PAA) random and block copolymers having bioreducible disulfide bonds in the ma...
The pH-responsive poly(amidoamine)s (PAAs) have been previously described. Whereas ISA23 enhances tr...
A review. Poly(amidoamine)s (PAAs) are a family of synthetic polymers obtained by stepwise polyaddn...
A review. Polymer--drug and polymer--protein conjugates are emerging as a robust and well-character...
Many potential therapeutics (such as genes, antisense and protein drugs) have their targets in a var...
On exposure to an acidic pH, linear poly(amidoamine)s (PAAs) cause membrane perturbation and consequ...
Poly(amidoamine)s were synthesized by polyaddition reaction: to bis-acryloylpiperazine of piperazine...
Bioresponsive poly(amidoamine)s (PAA)s are currently under development as endosomolytic polymers for...
Poly(amidoamine)s with bioreducible disulfide linkages in the main chain (SS-PAAs) and pH-responsive...
Poly(amidoamine)s with bioreducible disulfide linkages in the main chain (SS-PAAs) and pH-responsive...
Polymer–drug and polymer–protein conjugates are emerging as a robust and well-characterized class of...
Polymer–drug and polymer–protein conjugates are emerging as a robust and well-characterized class of...
Polymer–drug and polymer–protein conjugates are emerging as a robust and well-characterized class of...
Polymer–drug and polymer–protein conjugates are emerging as a robust and well-characterized class of...
In recent years, gene, antisense and ribozyme therapies have been proposed. These systems all share ...
Poly(amido amine) (SS-PAA) random and block copolymers having bioreducible disulfide bonds in the ma...
The pH-responsive poly(amidoamine)s (PAAs) have been previously described. Whereas ISA23 enhances tr...
A review. Poly(amidoamine)s (PAAs) are a family of synthetic polymers obtained by stepwise polyaddn...
A review. Polymer--drug and polymer--protein conjugates are emerging as a robust and well-character...